Hemophagocytic Lymphohistiocytosis Unknown Status Phase 1 / 2 Trials for Dexamethasone (DB01234)

Back to Hemophagocytic Lymphohistiocytosis

Also known as: Hemophagocytic Lymphohistiocytosis (HLH) / Haemophagocytic Lymphohistiocytosis / Hemophagocytic Lymphohistiocytoses / Hemophagocytic Lymphohisticytosis / Hemophagocytic lymphohistiocytosis (disorder) / Lymphohistiocytosis, Hemophagocytic / Primary hemophagocytic lymphohistiocytosis / Primary haemophagocytic lymphohistiocytosis / Familial hemophagocytic lymphohistiocytosis (disorder) / Familial Hemophagocytic Lymphocytosis / Familial haemophagocytic lymphohistiocytosis / Familial hemophagocytic lymphohistiocytosis

IndicationStatusPhase
DBCOND0029166 (Hemophagocytic Lymphohistiocytosis)Unknown Status1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03795909
Ruxolitinib Combined With Dexamethasone for HLHTreatment